About me
Tae Hyun (Ryan) Jung, Ph.D., is a Senior Statistical Reviewer in the Office of Biostatistics, Office of Translational Sciences, Center for Drug Evaluation and Research, FDA. He specializes in regulatory reviews of NDA/BLA/PMR submissions, with particular focus on RWE in rare diseases, pediatrics, pregnancy, urology, and reproductive medicine. At FDA, Dr. Jung leads critical regulatory research initiatives in RWE designs/methods, digital twin/synthetic patient data, and digital health technology applications in drug development. Dr. Jung earned his Ph.D. in Biostatistics from Yale University.
